BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/14/2025 12:55:54 PM | Browse: 8 | Download: 35
 |
Received |
|
2025-04-10 01:39 |
|
Peer-Review Started |
|
2025-04-10 01:39 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-04-22 12:24 |
|
Revised |
|
2025-05-01 05:12 |
|
Second Decision |
|
2025-05-29 02:49 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-05-29 07:24 |
|
Articles in Press |
|
2025-05-29 07:24 |
|
Publication Fee Transferred |
|
2025-05-07 04:59 |
|
Edit the Manuscript by Language Editor |
|
2025-06-04 18:33 |
|
Typeset the Manuscript |
|
2025-07-02 00:37 |
|
Publish the Manuscript Online |
|
2025-07-14 12:55 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Basic Study |
| Article Title |
BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mao Xiao, Zhi-Yan Luo, Ai-Ru Yu, Ke Xu and Wei Zhou |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Sichuan Medical Association Research Project |
Q2024049 |
| Clinical Science Research Fund of Chengdu Medical College |
24 LHLNYX1-03 |
| Chengdu Medical College Elite Peak Program |
2024qnGzn04 |
| Key Clinical Specialty of Sichuan Province |
YS00109 |
|
| Corresponding Author |
Wei Zhou, Department of Radiology, The First Affiliated Hospital of Chengdu Medical College, <label>6</label><institution-wrap><institution-id institution-id-type="GRID">grid.413856.d</institution-id><institution-id institution-id-type="ISNI">0000 0004 1799 3643</institution-id><institution>Clinical Medical College, </institution><institution>Chengdu Medical College, </institution></institution-wrap>Chengdu, Sichuan China, Chengdu 610500, Sichuan Province, China. zhouwei@cmc.edu.cn |
| Key Words |
Pancreatic cancer; Butyrophilin like 9; Cell division cycle 20; Cell cycle; Prognosis |
| Core Tip |
The present study reported the down-regulated expression of BTNL9 in pancreatic cancer (PC), which correlated with a poorer prognosis. PC cells overexpressing BTNL9 exhibited cell cycle arrest at the G2/M, accompanied by a reduction in their proliferative and metastatic capacity. BTNL9 regulates the cell cycle by inhibiting cell division cycle 20. |
| Publish Date |
2025-07-14 12:55 |
| Citation |
<p>Xiao M, Luo ZY, Yu AR, Xu K, Zhou W. BTNL9 exerts anti-cancer effects by inhibiting CDC20 to induce G2/M arrest in pancreatic cancer. <i>World J Gastrointest Oncol</i> 2025; 17(7): 108274</p> |
| URL |
https://www.wjgnet.com/1948-5204/full/v17/i7/108274.htm |
| DOI |
https://dx.doi.org/10.4251/wjgo.v17.i7.108274 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
